Comments
Loading...
Easton Pharmaceuticals Analyst Ratings and Price Targets | OTC:EAPH | Benzinga
Easton Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Easton Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Easton Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Easton Pharmaceuticals (EAPH) stock?
There is no price target for Easton Pharmaceuticals
What is the most recent analyst rating for Easton Pharmaceuticals (EAPH)?
There is no analyst for Easton Pharmaceuticals
When was the last upgrade for Easton Pharmaceuticals (EAPH)?
There is no last upgrade for Easton Pharmaceuticals
When was the last downgrade for Easton Pharmaceuticals (EAPH)?
There is no last downgrade for Easton Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Easton Pharmaceuticals (EAPH)?
There is no next analyst rating for Easton Pharmaceuticals.
Is the Analyst Rating Easton Pharmaceuticals (EAPH) correct?
There is no next analyst rating for Easton Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
